Sixth edition
by Joseph D. Nally
Good Manufacturing Practices for Pharmaceuticals Sixth Edition provides readers with fundamental knowledge of CGMP regulations and current industry applications and practices.
This Sixth Edition is significantly expanded to reflect the increase of information and changing practices in CGMP regulation and pharmaceutical manufacturing and control practices worldwide.
Good Manufacturing Practices for Pharmaceuticals Sixth Edition is an essential companion for every pharmaceutical professional
Each chapter has been updated and this book supplies new and must-have information regarding:
- the latest FDA guidance documents
- quality systems approach
- risk analysis and management
- quality by design
- standard operating procedures (SOPs), validation practices, and process analytical technology (PAT) initiatives
- contracting and outsourcing
- GMPs for Clinical Trial Materials
- active pharmaceutical ingredients (API) GMPs
- bulk pharmaceutical excipient GMPs and compliance
- equipment maintenance and calibration
- labeling regulations and applications
- failure investigations
- FDA enforcement tools
- inspection procedures, the pre-approval inspection process, and the Food and Drug Modernization Act
- worldwide GMP regulation
- ISO 9000 and Malcolm Baldrige approaches, and Six Sigma methodology
Contents
- Status and Applicability of U.S. Regulations
- Finished Pharmaceuticals General Provisions (Subpart A)
- Organization and Personnel (Subpart B)
- Buildings and Facilities (Subpart C)
- Equipment (Subpart D)
- Control of Components and Drug Product Containers and Closures (Subpart E)
- Production and Process Controls (Subpart F)
- Packaging and Labeling Control (Subpart G)
- Holding and Distribution (Subpart H)
- Laboratory Controls (Subpart I)
- Records and Reports (Subpart J)
- Returned and Salvaged Drug Products (Subpart K)
- Repacking and Relabeling
- Quality Systems and Risk Management Approaches
- Clinical Trial Supplies and GMPs
- Contracting and Outsourcing
- Active Pharmaceutical Ingredients
- Bulk Pharmaceutical Excipient GMPs
- Recalls, Warning Letter, Seizures and Injunctions: CGMP Enforcement Alternatives in the United States
- Controlled Substances Safeguards
- The Inspection Procedure for Compliance in the United States: The Regulatee Is Inspected
- The Rationale for Inspection
- FDA Pre-Approval Inspections/Investigations: The Road from SUPAC to the Food and Drug Modernization Act
- Worldwide GMPs
- Quality Approaches: ISO 9000, Malcolm Baldrige and Six Sigma
Appendices
- Center for Drug Evaluation and Research (CDER) List of Guidance Documents
- ICH Guidelines
- FDA/ORA Compliance Policy Guides
Index